Literature DB >> 28878849

Prognostic Value of Tumor-to-Blood Standardized Uptake Ratio in Patients with Resectable Non-Small-Cell Lung Cancer.

Seunghyeon Shin1, Kyoungjune Pak1, In Joo Kim1, Bum Soo Kim2, Seong Jang Kim2.   

Abstract

OBJECTIVES: Previously published studies showed that the standard tumor-to-blood standardized uptake value (SUV) ratio (SUR) was a more accurate prognostic method than tumor maximum standardized uptake value (SUVmax). This study evaluated and compared prognostic value of positron emission tomography (PET) parameters and normalized value of PET parameters by blood pool SUV in non-small-cell lung cancer (NSCLC) patients who received curative surgery.
METHODS: Seventy-seven patients who underwent curative resection for NSCLC between January 2010 to December 2013 were enrolled in this study. 18Fluorine-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) was performed before surgery. The mean standardized uptake value (SUVmean), SUVmax, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of each lesion was measured, on the workstation. SURmean, SURmax, and TLGSUR were calculated by dividing each of them by descending aorta SUVmean. Cox proportional hazards regression was used to analyze the effect of age, sex, pathological parameters, and PET parameters on recurrence and death.
RESULTS: In Cox regression analysis, N stage predicted for both recurrence (p < 0.0001) and death (p < 0.0001). SURmax predicted recurrence (p = 0.0014), not death. Area under the receiver operating characteristic curve of SURmax was 0.759 with cutoff value 4.004. However, SUVmax, SUVmean, MTV, TLG, SURmean, and TLGSUR predicted neither recurrence nor death.
CONCLUSIONS: Among PET parameters, SURmax was the independent predictor of recurrence in NSCLC patients who received curative surgery. N stage was the independent prognostic factor for both recurrence and death. Both parameters could be used to stratify the risk of NSCLC patients.

Entities:  

Keywords:  Fluorodeoxyglucose F18; Non-small-cell lung cancer; Positron-emission tomography; Prognosis; Recurrence; Survival

Year:  2016        PMID: 28878849      PMCID: PMC5567617          DOI: 10.1007/s13139-016-0456-3

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  26 in total

1.  18F-fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma.

Authors:  Myeong Jun Song; Si Hyun Bae; Sung Won Lee; Do Sun Song; Hee Yeon Kim; Ie Ryung Yoo; Joon-Il Choi; Young June Lee; Ho Jong Chun; Hae Giu Lee; Jong Young Choi; Seung Kew Yoon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-22       Impact factor: 9.236

2.  Is liver SUV stable over time in ¹⁸F-FDG PET imaging?

Authors:  Eric Laffon; Xavier Adhoute; Henri de Clermont; Roger Marthan
Journal:  J Nucl Med Technol       Date:  2011-08-30

3.  Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: standardized uptake value corrected by mean liver standardized uptake value.

Authors:  Satoshi Shiono; Masami Abiko; Toshimasa Okazaki; Masato Chiba; Hiroshi Yabuki; Toru Sato
Journal:  Eur J Cardiothorac Surg       Date:  2011-04-19       Impact factor: 4.191

4.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

5.  Prediction for recurrence using F-18 FDG PET/CT in pathologic N0 lung adenocarcinoma after curative surgery.

Authors:  Do-Hoon Kim; Seung Hyun Son; Choon-Young Kim; Chae Moon Hong; Jong-Ryool Oh; Bong-Il Song; Hae Won Kim; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Ann Surg Oncol       Date:  2013-09-18       Impact factor: 5.344

6.  Variability of lesion detectability and standardized uptake value according to the acquisition procedure and reconstruction among five PET scanners.

Authors:  Yasuyuki Takahashi; Noboru Oriuchi; Hidenori Otake; Keigo Endo; Kenya Murase
Journal:  Ann Nucl Med       Date:  2008-08-01       Impact factor: 2.668

7.  Advanced non-small cell lung cancer in the elderly: the impact of age and comorbidities on treatment modalities and patient prognosis.

Authors:  Chia-Lin Hsu; Jen-Hau Chen; Kuan-Yu Chen; Jin-Yuan Shih; James Chih-Hsin Yang; Chong-Jen Yu; Pan-Chyr Yang
Journal:  J Geriatr Oncol       Date:  2014-09-22       Impact factor: 3.599

8.  Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis.

Authors:  Hyung-Jun Im; Kyoungjune Pak; Gi Jeong Cheon; Keon Wook Kang; Seong-Jang Kim; In-Joo Kim; June-Key Chung; E Edmund Kim; Dong Soo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09-06       Impact factor: 9.236

9.  Age is a prognostic factor affecting survival in lung cancer patients.

Authors:  Faruk Tas; Rumeysa Ciftci; Leyla Kilic; Senem Karabulut
Journal:  Oncol Lett       Date:  2013-09-06       Impact factor: 2.967

10.  The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG.

Authors:  Jörg van den Hoff; Liane Oehme; Georg Schramm; Jens Maus; Alexandr Lougovski; Jan Petr; Bettina Beuthien-Baumann; Frank Hofheinz
Journal:  EJNMMI Res       Date:  2013-11-23       Impact factor: 3.138

View more
  5 in total

1.  Test-Retest Variability in Lesion SUV and Lesion SUR in 18F-FDG PET: An Analysis of Data from Two Prospective Multicenter Trials.

Authors:  Frank Hofheinz; Ivayla Apostolova; Liane Oehme; Jörg Kotzerke; Jörg van den Hoff
Journal:  J Nucl Med       Date:  2017-05-04       Impact factor: 10.057

2.  18F-FDG PET/CT radiomics nomogram for predicting occult lymph node metastasis of non-small cell lung cancer.

Authors:  Jianyi Qiao; Xin Zhang; Ming Du; Pengyuan Wang; Jun Xin
Journal:  Front Oncol       Date:  2022-09-28       Impact factor: 5.738

3.  Correlation between Reference Tissue Normalized 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Standardized Uptake Value Max of Nodal and Extranodal Sites in Lymphomas: An Empirical Study.

Authors:  Mannam Pallavi; Arunan Murali; Gokulakrishnan Periakaruppan; Venkatachalapathy Easwaramoorthy; Venkata Sai Pulivadula Mohanarangam
Journal:  Indian J Nucl Med       Date:  2021-12-15

Review 4.  PET/CT for Predicting Occult Lymph Node Metastasis in Gastric Cancer.

Authors:  Danyu Ma; Ying Zhang; Xiaoliang Shao; Chen Wu; Jun Wu
Journal:  Curr Oncol       Date:  2022-09-11       Impact factor: 3.109

5.  The predictive value of total-body PET/CT in non-small cell lung cancer for the PD-L1 high expression.

Authors:  Bingxin Hu; Huibin Jin; Xiali Li; Xinyu Wu; Junling Xu; Yongju Gao
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.